CIK: 0001582844 · Show all filings
Period: Q2 2023 (← Previous) (Next →)
Filing Date: Aug 14, 2023
Total Value ($000): $147,605 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| APLS | APELLIS PHARMACEUTICALS INC | 297,596 | $27,111 | 18.4% | $44.70 | +93.0% | COM | 03753U106 |
| WHWK | AADI BIOSCIENCES INC | 1,849,402 | $12,650 | 8.6% | $27.48 | -71.7% | COM | 00032Q104 |
| TERN | TERNS PHARMACEUTICALS INC | 970,000 | $8,488 | 5.8% | $5.72 | +103.8% | COM | 880881107 |
| KURA | KURA ONCOLOGY INC. COMMON STOCK | 709,118 | $7,502 | 5.1% | $14.15 | -16.4% | COM | 50127T109 |
| SNDX | SYNDAX PHARMACEUTICALS INC | 299,841 | $6,276 | 4.3% | $19.65 | +5.9% | COM | 87164F105 |
| IRON | DISC MEDICINE INC | 139,500 | $6,194 | 4.2% | $35.48 | 0.0% | COM | 254604101 |
| PCVX | VAXCYTE INC | 122,166 | $6,101 | 4.1% | $31.29 | +51.5% | COM | 92243G108 |
| RCKT | ROCKET PHARMACEUTICALS INC | 306,194 | $6,084 | 4.1% | $18.61 | +8.6% | COM | 77313F106 |
| VRDN | VIRIDIAN THERAPEUTICS INC | 224,707 | $5,346 | 3.6% | $19.84 | +29.3% | COM | 92790C104 |
| — | IVERIC BIO INC | 131,454 | $5,171 | 3.5% | $7.63 | — | COM | 46583P102 |
| ARGX | ARGENX SE | 12,568 | $4,898 | 3.3% | $379.17 | — | SPONSORED ADR | 04016X101 |
| — | PRAXIS PRECISION MEDICINES I | 4,250,000 | $4,888 | 3.3% | $1.15 | — | COM | 74006W108 |
| VTYX | VENTYX BIOSCIENCES INC | 147,318 | $4,832 | 3.3% | $21.58 | +59.8% | COM | 92332V107 |
| — | CYMABAY THERAPEUTICS INC. COMMON STOCK | 430,000 | $4,709 | 3.2% | $6.27 | — | COM | 23257D103 |
| CLDX | CELLDEX THERAPEUTICS INC | 122,343 | $4,151 | 2.8% | $9.46 | +256.2% | COM NEW | 15117B202 |
| — | CLENE INC | 4,240,846 | $3,732 | 2.5% | $0.88 | — | COMMON STOCK | 185634102 |
| — | IKENA ONCOLOGY INC | 558,000 | $3,660 | 2.5% | $6.56 | — | COM | 45175G108 |
| EYPT | EYEPOINT PHARMACEUTICALS INC | 382,000 | $3,323 | 2.3% | $10.15 | -39.8% | COM NEW | 30233G209 |
| GHRS | GH RESEARCH PLC | 244,828 | $2,905 | 2.0% | $20.48 | -49.9% | ORDINARY SHARES | G3855L106 |
| IMVT | IMMUNOVANT INC | 141,755 | $2,689 | 1.8% | $18.65 | 0.0% | COM | 45258J102 |
| VSTM | VERASTEM INC | 300,000 | $2,232 | 1.5% | $6.94 | 0.0% | COM NEW | 92337C203 |
| ROIV | ROIVANT SCIENCES LTD | 220,000 | $2,218 | 1.5% | $8.94 | 0.0% | SHARES | G76279101 |
| ELVN | ENLIVEN THERAPEUTICS INC | 104,500 | $2,133 | 1.4% | $20.25 | -0.2% | COM | 29337E102 |
| ALKS | ALKERMES PLC | 44,689 | $1,399 | 0.9% | $28.13 | +7.6% | SHS | G01767105 |
| ACRS | ACLARIS THERAPEUTICS | 121,692 | $1,262 | 0.9% | $16.22 | -44.2% | COM | 00461U105 |
| — | HILLEVAX INC | 63,078 | $1,084 | 0.7% | $17.12 | — | COM | 43157M102 |
| — | MORPHIC HOLDING INC | 17,500 | $1,003 | 0.7% | $57.33 | — | COM | 61775R105 |
| ARWR | ARROWHEAD PHARMACEUTICALS INC | 27,500 | $981 | 0.7% | $34.48 | 0.0% | COM | 04280A100 |
| OLMA | OLEMA PHARMACEUTICALS INC | 105,814 | $956 | 0.6% | $6.04 | 0.0% | COM | 68062P106 |
| BMEA | BIOMEA FUSION INC | 40,000 | $878 | 0.6% | $31.30 | 0.0% | COM | 09077A106 |
| DYN | DYNE THERAPEUTICS INC | 73,000 | $821 | 0.6% | $11.80 | 0.0% | COM | 26818M108 |
| RZLT | REZOLUTE INC | 373,400 | $739 | 0.5% | $3.30 | -37.6% | COM NEW | 76200L309 |
| SVRA | SAVARA INC | 198,139 | $633 | 0.4% | $2.25 | +4.3% | COM | 805111101 |
| — | KRONOS BIO INC | 315,000 | $542 | 0.4% | $1.72 | — | COM | 50107A104 |
| — | NUVATION BIO INC | 90,832 | $15 | 0.0% | $0.28 | — | *W EXP 07/07/2027 | 67080N119 |